Search
Phio Pharmaceuticals Corp
PHIOAdd to Watchlist
1.020USD
-0.020-1.92%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
11.85MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-24The current earnings forecast score of Phio Pharmaceuticals Corp is 8.00, ranking 167 out of 388 in the Biotechnology & Medical Research industry. The average price target is 14.00, with a high of 14.00 and a low of 14.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
14.000
Target Price
+1259.22%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Phio Pharmaceuticals Corp
PHIO
1
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
IQVIA Holdings Inc
IQV
26
CRISPR Therapeutics AG
CRSP
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Phio Pharmaceuticals Corp's price target?
Analysts forecast that Phio Pharmaceuticals Corp's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.
How have Phio Pharmaceuticals CorpPHIO's recent earnings per share performed?
The market expectation was USD -0.34, while Phio Pharmaceuticals CorpPHIO's earnings per share (EPS) for the previous quarter was USD -0.25. EPS for the next quarter is expected at USD -0.36.
What is the analyst rating for Phio Pharmaceuticals Corp?
Based on the ratings of Phio Pharmaceuticals Corp's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
